News

Press Release | January 4, 2019

Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets

Read More

News | December 18, 2018

Palvella Therapeutics Announces $10 Million in Funding from Ligand Pharmaceuticals to Accelerate PTX-022 through Phase 2/3 Clinical Study in Pachyonychia Congenita

Read More

Press Release | December 13, 2018

Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California

Read More

Press Release | December 6, 2018

Precision BioSciences and Durham STEM Students Lead Launch of First Genome Editing Experiment Into Space

Read More

News | November 27, 2018

Precision BioSciences Receives FDA Authorization to Initiate Clinical Study of Gene Edited Cancer Immunotherapy

Read More

News | November 20, 2018

Pliant Therapeutics Receives FDA Orphan Drug Designation for Lead Program PLN-74809 in Primary Sclerosing Cholangitis

Read More

Uncategorized | June 27, 2018

Carisma Therapeutics Announces a $53 Million Series A Financing

Read More